CRISPR Gene Therapy Cures Sickle Cell Disease in Landmark Clinical Trial
All 45 patients in a Phase 3 trial achieved complete disease remission after a single treatment, marking a watershed moment for genetic medicine.
Dr. Marcus Brown//Apr 20, 2026//8m